Sandu Pharmaceuticals Ltd — Updates, 03-06-2025: Company Update

Sandu Pharmaceuticals has received a show cause notice from the Maharashtra GST Department for alleged excess input tax credit claimed amounting to Rs. 96.48 lakh, including interest and penalty. The issues relate to discrepancies in ITC claims and liability reconciliation. The company plans to respond to the notice and, based on its internal review and legal advice, is confident of a favorable resolution. It does not foresee any impact on its financials or operations due to this matter.